4//SEC Filing
Shearman Mark S 4
Accession 0001179110-21-011225
CIK 0001650664other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:10 PM ET
Size
4.8 KB
Accession
0001179110-21-011225
Insider Transaction Report
Form 4
Shearman Mark S
EVP, Chief Scientific Officer
Transactions
- Award
Common Stock
2021-12-22+9,084→ 41,785 total
Footnotes (1)
- [F1]Reflects the acquisition, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on June 14, 2021. The shares subject to the restricted stock unit award remain subject to time-based vesting conditions and will vest on June 14, 2022, subject to continued service.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001643799
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:10 PM ET
- Size
- 4.8 KB